MedTrace Logo

Evaluate Esophageal Reinforcement With ACell MatriStem Surgical Matrix: A Degradable Biologic Scaffold Material

NCT01970306 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2023-11-03

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to see if implanting MatriStem will lower the risk of one of the more common complications after stomach or esophagus surgery.

Conditions

  • Esophageal Adenocarcinoma

Interventions

DEVICE

MatriStem PSM

All esophageal anastomoses will be reinforced circumferentially with ACell MatriStem PSM.

Sponsors & Collaborators

Principal Investigators

  • Vivian Strong, MD · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-18
Primary Completion
2023-02-24
Completion
2023-02-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01970306 on ClinicalTrials.gov